Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20200106046023N1
IRCT20200106046023N1
Completed
Phase 2

Assessment of the botulinum toxin type A effect on Intensified Raynauds Phenomenon in Sclerodermic patients

Oroumia University of Medical Sciences0 sites11 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSystemic sclerosis [scleroderma].Systemic sclerosis [scleroderma]

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Systemic sclerosis [scleroderma].
Sponsor
Oroumia University of Medical Sciences
Enrollment
11
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Oroumia University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • •Patients with scleroderma based on ACR criteria
  • •Patients with Age over 18 years
  • •Intensified and Resistant Raynauds

Exclusion Criteria

  • •A history of allergy to Botox
  • •History of myasthenia gravis disease
  • •Pregnancy and lactation
  • •Taking estrogen\-containing pills in the last month
  • •History of vascular surgery and sympathectomy
  • •Consumption of Aminoglycoside Antibiotics
  • •The presence of active infection
  • •The presence of severe bleeding tendency

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
comparison of the effect of botulinium toxin A injection with placebo in reducing the pain of patients with myofacial paitemporomandibular disorder.Temporomandibular joint disorders
IRCT2016051527894N2Vice chancellor for research of Ahvaz Jundishapur University of Medical Sciences34
Active, not recruiting
Not Applicable
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with a stiff knee gait. - Botulinum toxin type A injections in stiff knee gaitStroke patients with stiff knee gait. Stiff knee gait is characterized as a diminished knee flexion during swing phase of gait. It is common in stroke patients.
EUCTR2009-018226-29-NL26
Completed
Phase 3
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with stiff knee gaitstiff knee gaitstiff-legged knee1000796310057166
NL-OMON39359Revalidatiecentrum Het Roessingh26
Active, not recruiting
Phase 4
To check wrinkle free forehead after injection of Botulinum drug.
CTRI/2015/03/005613Dr L Krishna Prasad Head of department Department of oral and maxillofacial surgery
Recruiting
Phase 3
Evaluation the effect of Botulinium toxin injection on improving symptoms in patients with diabetic neuropathy
IRCT20240116060710N1Shahid Beheshti University of Medical Sciences30